Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The highest variance explained (marginal correlation, CAR score, “Methods”) by cis-pQTLs were for the rs7041 polymorphism and vitamin D-binding protein (65.6%), rs2856448 for the Tenascin-X protein (61.5%) and rs60642321 for the Complement factor H-related protein 1 (54.4%).

Source: Contribution of human genetics on plasma protein levels. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were selected based on stringent inclusion and exclusion criteria, as detailed elsewhere [].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes

Study design awaiting verification · Genome Medicine · 2022

Original publication title

Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes

Barthelemy Caron; Etienne Patin; Maxime Rotival; Bruno Charbit; Matthew L. Albert; Lluis Quintana-Murci; Darragh Duffy; Antonio Rausell; the Milieu Intérieur ConsortiumAbelLaurentAlcoverAndresAschardHuguesBoussoPhilippeBourkeNollaigBrodinPetterBruhnsPierreCerf-BensussanNadineCumanoAnaDemangelCarolined’EnfertChristopheDerianoLudovicDilliesMarie-AgnèsDi SantoJamesDromerFrançoiseEberlGérardEnningaJostFellayJacquesGomperts-BonecaIvoHasanMilenaFontesMagnusHedestamGunilla KarlssonHercbergSergeIngersollMolly A.KennyRose AnneLantzOlivierMichelFrédériqueMouquetHugoO’FarrellyClionaPatinEtiennePellegriniSandraPolStanislasRausellAntonioRieux-LaucatFrédéricRoggeLarsSakuntabhaiAnavajSchwartzOlivierSchwikowskiBennoShorteSpencerTangyFrédéricToubertAntoineTouvierMathildeUngeheuerMarie-NoëlleZimmerChristopheAlbertMatthew L.DuffyDarraghQuintana-MurciLluis

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our study identified novel genetic and non-genetic factors associated to plasma protein levels which may inform health status and disease management.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Blood plasma proteins play an important role in immune defense against pathogens, including cytokine signaling, the complement system, and the acute-phase response. Recent large-scale studies have reported genetic (i.e., protein quantitative trait loci, pQTLs) and non-genetic factors, such as age and sex, as major determinants to inter-individual variability in immune response variation. However, the contribution of blood-cell composition to plasma protein heterogeneity has not been fully characterized and may act as a mediating factor in association studies.

Source: Background

Abstract: What methods does the paper describe?

Here, we evaluated plasma protein levels from 400 unrelated healthy individuals of western European ancestry, who were stratified by sex and two decades of life (20 to 29 and 60 to 69 years), from the Milieu Intérieur cohort. We quantified 229 proteins by Luminex in a clinically certified laboratory and their levels of variation were analyzed together with 5.2 million single-nucleotide polymorphisms. With respect to non-genetic variables, we included 254 lifestyle and biochemical factors, as well as counts of seven circulating immune cell populations measured by hemogram and standardized flow cytometry.

Source: Methods

Abstract: Results

Collectively, we found 152 significant associations involving 49 proteins and 20 non-genetic variables. Consistent with previous studies, age and sex showed a global, pervasive impact on plasma protein heterogeneity, while body mass index and other health status variables were among the non-genetic factors with the highest number of associations. After controlling for these covariates, we identified 100 and 12 pQTLs acting in cis and trans, respectively, collectively associated with 87 plasma proteins and including 19 novel genetic associations. Genetic factors explained the largest fraction of the variability of plasma protein levels, as compared to non-genetic factors.

In addition, blood-cell fractions, including leukocytes, lymphocytes, monocytes, neutrophils, eosinophils, basophils, and platelets, had a larger contribution to inter-individual variability than age and sex and appeared as confounders of specific genetic associations. Finally, we identified new genetic associations with plasma protein levels of five monogenic Mendelian disease genes including two primary immunodeficiency genes (Ficolin-3 and FAS).

Source: Results

Abstract: Conclusions

Our study identified novel genetic and non-genetic factors associated to plasma protein levels which may inform health status and disease management.

Source: Conclusions
Authors’ abstract

Background

Blood plasma proteins play an important role in immune defense against pathogens, including cytokine signaling, the complement system, and the acute-phase response. Recent large-scale studies have reported genetic (i.e., protein quantitative trait loci, pQTLs) and non-genetic factors, such as age and sex, as major determinants to inter-individual variability in immune response variation. However, the contribution of blood-cell composition to plasma protein heterogeneity has not been fully characterized and may act as a mediating factor in association studies.

Methods

Here, we evaluated plasma protein levels from 400 unrelated healthy individuals of western European ancestry, who were stratified by sex and two decades of life (20 to 29 and 60 to 69 years), from the Milieu Intérieur cohort. We quantified 229 proteins by Luminex in a clinically certified laboratory and their levels of variation were analyzed together with 5.2 million single-nucleotide polymorphisms. With respect to non-genetic variables, we included 254 lifestyle and biochemical factors, as well as counts of seven circulating immune cell populations measured by hemogram and standardized flow cytometry.

Results

Collectively, we found 152 significant associations involving 49 proteins and 20 non-genetic variables. Consistent with previous studies, age and sex showed a global, pervasive impact on plasma protein heterogeneity, while body mass index and other health status variables were among the non-genetic factors with the highest number of associations. After controlling for these covariates, we identified 100 and 12 pQTLs acting in cis and trans, respectively, collectively associated with 87 plasma proteins and including 19 novel genetic associations. Genetic factors explained the largest fraction of the variability of plasma protein levels, as compared to non-genetic factors.

In addition, blood-cell fractions, including leukocytes, lymphocytes, monocytes, neutrophils, eosinophils, basophils, and platelets, had a larger contribution to inter-individual variability than age and sex and appeared as confounders of specific genetic associations. Finally, we identified new genetic associations with plasma protein levels of five monogenic Mendelian disease genes including two primary immunodeficiency genes (Ficolin-3 and FAS).

Conclusions

Our study identified novel genetic and non-genetic factors associated to plasma protein levels which may inform health status and disease management.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13073-022-01032-y.

Publication and source details

Original title: Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes

Barthelemy Caron; Etienne Patin; Maxime Rotival; Bruno Charbit; Matthew L. Albert; Lluis Quintana-Murci; Darragh Duffy; Antonio Rausell; the Milieu Intérieur ConsortiumAbelLaurentAlcoverAndresAschardHuguesBoussoPhilippeBourkeNollaigBrodinPetterBruhnsPierreCerf-BensussanNadineCumanoAnaDemangelCarolined’EnfertChristopheDerianoLudovicDilliesMarie-AgnèsDi SantoJamesDromerFrançoiseEberlGérardEnningaJostFellayJacquesGomperts-BonecaIvoHasanMilenaFontesMagnusHedestamGunilla KarlssonHercbergSergeIngersollMolly A.KennyRose AnneLantzOlivierMichelFrédériqueMouquetHugoO’FarrellyClionaPatinEtiennePellegriniSandraPolStanislasRausellAntonioRieux-LaucatFrédéricRoggeLarsSakuntabhaiAnavajSchwartzOlivierSchwikowskiBennoShorteSpencerTangyFrédéricToubertAntoineTouvierMathildeUngeheuerMarie-NoëlleZimmerChristopheAlbertMatthew L.DuffyDarraghQuintana-MurciLluis

Genome Medicine · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.agence nationale de la recherche (fr)ANR-10-LABX-69-01.Grant ANR-10-IAHU-01

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T09:59:20.972590+00:00

DOI: 10.1186/s13073-022-01032-y · PMC8905727